Gene- and cell-based therapies for cardiovascular diseases: current status and future directions

[1]  M. Gnecchi,et al.  Gene and cell‐based therapies for heart disease , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  M. Loda,et al.  Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus. , 2004, Biochemical and biophysical research communications.

[3]  Seil Oh,et al.  Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation , 2003, Circulation.

[4]  R. Mulligan,et al.  Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts: Implications for Cell-Based Vascular Therapy , 2003, Circulation.

[5]  Craig Pratt,et al.  A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. , 2003, Journal of the American College of Cardiology.

[6]  Michael D. Schneider,et al.  Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[8]  Clotilde Castaldo,et al.  Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Hristov,et al.  Endothelial progenitor cells: mobilization, differentiation, and homing. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  U. Dirnagl,et al.  Estrogen Increases Bone Marrow‐Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation , 2003, Circulation.

[11]  Shahin Rafii,et al.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.

[12]  K. Alitalo,et al.  Gene transfer as a tool to induce therapeutic vascular growth , 2003, Nature Medicine.

[13]  T. Matsuda,et al.  Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. , 2003, Biomaterials.

[14]  Elazer R Edelman,et al.  Tissue Engineering Therapy for Cardiovascular Disease , 2003, Circulation research.

[15]  James T. Willerson,et al.  Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.

[16]  R. Kloner,et al.  Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? , 2003, Cardiovascular research.

[17]  H. Masuda,et al.  Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. , 2003, Cardiovascular research.

[18]  J. Bagley,et al.  Gene Therapy Progress and Prospects: Gene therapy in organ transplantation , 2003, Gene Therapy.

[19]  J. Isner,et al.  Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.

[20]  Y. Yoon,et al.  Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.

[21]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[22]  Hung-Fat Tse,et al.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation , 2003, The Lancet.

[23]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[24]  Yan Huang,et al.  Induction of angiogenesis in a mouse model using engineered transcription factors , 2002, Nature Medicine.

[25]  H. Matsubara,et al.  Improvement of Collateral Perfusion and Regional Function by Implantation of Peripheral Blood Mononuclear Cells Into Ischemic Hibernating Myocardium , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Ruediger C. Braun-Dullaeus,et al.  Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies , 2002, Nature Medicine.

[27]  J. Bräsen,et al.  Adenovirus-Mediated Extracellular Superoxide Dismutase Gene Therapy Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta , 2002, Circulation.

[28]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[29]  M. Endres,et al.  Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation: Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[30]  G. Kojda,et al.  Vasoprotection by nitric oxide: mechanisms and therapeutic potential. , 2002, Cardiovascular research.

[31]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2002, Nature.

[32]  J. Isner,et al.  Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.

[33]  L. Sauvage,et al.  Utilizing Granulocyte Colony-stimulating Factor to Enhance Vascular Graft Endothelialization from Circulating Blood Cells , 2002, Annals of vascular surgery.

[34]  R. Hendel,et al.  Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia , 2002, Circulation.

[35]  Akira Takeshita,et al.  Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E–Knockout Mice , 2002, Circulation.

[36]  C. Grines,et al.  Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris , 2002, Circulation.

[37]  Stuart S Berr,et al.  Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. , 2002, American journal of physiology. Heart and circulatory physiology.

[38]  J. Isner,et al.  Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration , 2002, Circulation.

[39]  R. H. Sohn,et al.  Early Loss of Thrombomodulin Expression Impairs Vein Graft Thromboresistance: Implications for Vein Graft Failure , 2002, Circulation research.

[40]  J. Oyama,et al.  Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene , 2002, Circulation.

[41]  P. Insulander,et al.  Catheter-based transendocardial myocardial gene transfer. , 2002, Journal of interventional cardiology.

[42]  R. Cartier,et al.  Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems , 2002, Gene Therapy.

[43]  J. Isner.  Myocardial gene therapy , 2002, Nature.

[44]  W. Durante,et al.  Adenovirus-Mediated Heme Oxygenase-1 Gene Delivery Inhibits Injury-Induced Vascular Neointima Formation , 2001, Circulation.

[45]  M. Mccarthy.  Molecular decoy may keep bypass grafts open , 2001, The Lancet.

[46]  D. Shum-Tim,et al.  The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. , 2001, The Journal of thoracic and cardiovascular surgery.

[47]  S. Shyue,et al.  Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2001, Circulation.

[48]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[49]  A. Kosaki,et al.  Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines , 2001, Circulation.

[50]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A M Zeiher,et al.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.

[52]  M. Bennett,et al.  Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. , 2001, Pharmacology & therapeutics.

[53]  J. Isner,et al.  HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. , 2001, The Journal of clinical investigation.

[54]  Z. Katušić,et al.  Gene transfer of manganese superoxide dismutase reverses vascular dysfunction in the absence but not in the presence of atherosclerotic plaque. , 2001, Human gene therapy.

[55]  R. Hajjar,et al.  Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo , 2001, Circulation.

[56]  S. Fichtlscherer,et al.  Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease , 2001, Circulation.

[57]  T. Murohara,et al.  Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction , 2001, Circulation.

[58]  H. E. von der Leyen,et al.  Therapeutic potential of nitric oxide synthase gene manipulation. , 2001, Circulation.

[59]  N. Weissman,et al.  Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. , 2001, Journal of the American College of Cardiology.

[60]  J. Isner,et al.  Randomized, Single-Blind, Placebo-Controlled Pilot Study of Catheter-Based Myocardial Gene Transfer for Therapeutic Angiogenesis Using Left Ventricular Electromechanical Mapping in Patients With Chronic Myocardial Ischemia , 2001, Circulation.

[61]  B. A. French,et al.  Gene Therapy With Extracellular Superoxide Dismutase Protects Conscious Rabbits Against Myocardial Infarction , 2001, Circulation.

[62]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[63]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[64]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[65]  T. Murohara,et al.  Augmentation of Postnatal Neovascularization With Autologous Bone Marrow Transplantation , 2001, Circulation.

[66]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[67]  D. Mohuczy,et al.  Attenuation of Hypertension and Heart Hypertrophy by Adeno-Associated Virus Delivering Angiotensinogen Antisense , 2001, Hypertension.

[68]  A. Hagège,et al.  Myoblast transplantation for heart failure , 2001, The Lancet.

[69]  D. Lefer,et al.  Oxidative stress and cardiac disease. , 2000, The American journal of medicine.

[70]  H. Blau,et al.  VEGF gene delivery to myocardium: deleterious effects of unregulated expression. , 2000, Circulation.

[71]  E. Edelman,et al.  Endothelial cell delivery for cardiovascular therapy. , 2000, Advanced drug delivery reviews.

[72]  L. Sauvage,et al.  Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small-caliber synthetic vascular grafts. , 2000, Journal of vascular surgery.

[73]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[74]  M. Kibbe,et al.  Gene therapy for restenosis. , 2000, Circulation research.

[75]  M. Matsuzaki,et al.  Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. , 2000, The Journal of surgical research.

[76]  R. Kitsis,et al.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.

[77]  J. Willerson,et al.  Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor. , 2000, Circulation.

[78]  J. Isner,et al.  Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. , 1999, Human gene therapy.

[79]  D. Mohuczy,et al.  Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension. , 1999, American journal of physiology. Heart and circulatory physiology.

[80]  S. Hanson,et al.  Reduction in vascular lesion formation by hirudin secreted from retrovirus-transduced confluent endothelial cells on vascular grafts in baboons. , 1999, Circulation.

[81]  R. Weisel,et al.  Autologous transplantation of bone marrow cells improves damaged heart function. , 1999, Circulation.

[82]  J. Polak,et al.  Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial , 1999, The Lancet.

[83]  D. Rader,et al.  Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. , 1999, Circulation.

[84]  M. Raizada,et al.  Sustained inhibition of angiotensin I-converting enzyme (ACE) expression and long-term antihypertensive action by virally mediated delivery of ACE antisense cDNA. , 1999, Circulation research.

[85]  R. Poston,et al.  Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. , 1999, Transplantation.

[86]  J. Chamberlain,et al.  Improved Production of Gutted Adenovirus in Cells Expressing Adenovirus Preterminal Protein and DNA Polymerase , 1999, Journal of Virology.

[87]  J. Isner,et al.  Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. , 1999, The Annals of thoracic surgery.

[88]  K. Propert,et al.  Immune responses to adenovirus and adeno-associated virus in humans , 1999, Gene Therapy.

[89]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[90]  M. Post,et al.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. , 1999, Circulation.

[91]  C. Murry,et al.  Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. , 1999, Circulation.

[92]  K. Channon,et al.  Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. , 1999, Circulation.

[93]  K. Matsumoto,et al.  Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. , 1999, The Annals of thoracic surgery.

[94]  Haruchika Masuda,et al.  Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.

[95]  E. Edelman,et al.  Endothelial implants inhibit intimal hyperplasia after porcine angioplasty. , 1999, Circulation research.

[96]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[97]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[98]  V. Palace,et al.  The role of oxidative stress in the genesis of heart disease. , 1998, Cardiovascular research.

[99]  Doris A Taylor,et al.  Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation , 1998, Nature Medicine.

[100]  M. Soonpaa,et al.  Survey of studies examining mammalian cardiomyocyte DNA synthesis. , 1998, Circulation research.

[101]  M. Mann,et al.  Cell cycle progression: new therapeutic target for vascular proliferative disease. , 1998, Circulation.

[102]  A. Quyyumi.  Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. , 1998, The American journal of medicine.

[103]  L. Chao,et al.  Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. , 1998, Human gene therapy.

[104]  J. Loscalzo,et al.  Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.

[105]  R. Schwartz,et al.  Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. , 1998, The American journal of cardiology.

[106]  M. Kuo,et al.  Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. , 1998, Circulation research.

[107]  T. Drake,et al.  Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. , 1997, The Journal of thoracic and cardiovascular surgery.

[108]  M. Mann,et al.  Genetic manipulation of vein grafts. , 1997, Current opinion in cardiology.

[109]  A. Takeshita,et al.  Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[110]  K. Webster,et al.  Regulated expression of a foreign gene targeted to the ischaemic myocardium. , 1997, Cardiovascular research.

[111]  L. Chao,et al.  Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. , 1997, Hypertension.

[112]  J. Isner,et al.  Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA. , 1997, Cardiovascular research.

[113]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[114]  P. Tsao,et al.  Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts. , 1997, The Journal of clinical investigation.

[115]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[116]  Y. Ho,et al.  Transgenic mice overexpressing glutathione peroxidase are resistant to myocardial ischemia reperfusion injury. , 1996, Journal of molecular and cellular cardiology.

[117]  Peipei Ping,et al.  Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart , 1996, Nature Medicine.

[118]  Simon C Watkins,et al.  Vascular Gene Transfer of the Human Inducible Nitric Oxide Synthase: Characterization of Activity and Effects on Myointimal Hyperplasia , 1996, Molecular medicine.

[119]  D. Dichek,et al.  Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. , 1996, Circulation.

[120]  D. Rader,et al.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia , 1995, Nature Medicine.

[121]  J. Leiden,et al.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.

[122]  J. Isner,et al.  Gene therapy for the vulnerable plaque. , 1995, Journal of the American College of Cardiology.

[123]  T. Ogihara,et al.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  P. Tsao,et al.  Genetic engineering of vein grafts resistant to atherosclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[126]  H. Gold,et al.  Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. , 1994, Circulation.

[127]  T. Ogihara,et al.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[128]  D. Dichek,et al.  Seeding of intravascular stents with genetically engineered endothelial cells. , 1989, Circulation.

[129]  P. Libby,et al.  Implantation of vascular grafts lined with genetically modified endothelial cells. , 1989, Science.

[130]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[131]  T. Flotte,et al.  Virus-Based Gene Delivery Systems , 2002, Clinical pharmacokinetics.

[132]  J. Isner,et al.  Angiogenic gene therapy: pre-clinical studies and phase I clinical data. , 2002, Kidney international.

[133]  F. Sellke,et al.  Gene transfer for angiogenesis in coronary artery disease. , 2001, Annual review of medicine.

[134]  R M Nerem,et al.  Vascular tissue engineering. , 2001, Annual review of biomedical engineering.

[135]  R. Samulski,et al.  AAV vectors: is clinical success on the horizon? , 2000, Gene Therapy.

[136]  D. Trono.  Lentiviral vectors: turning a deadly foe into a therapeutic agent , 2000, Gene Therapy.

[137]  R. Crystal,et al.  Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. , 2000, The Annals of thoracic surgery.

[138]  P. Consigny.  Endothelial cell seeding on prosthetic surfaces. , 2000, Journal of long-term effects of medical implants.

[139]  R. Crystal,et al.  Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. , 1998, The Journal of thoracic and cardiovascular surgery.

[140]  Von der Leyen.  Gene therapy inhibiting neointimal vascular lesion , 1995 .